NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

Malcolm Rowland, PhD

Practice Area Focus

  • Development Strategy
  • Clinical Pharmacology
  • Technology Assessment


Prof Rowland, a Founder and Partner in NDA Partners, is recognized as an innovator and world leader in the fields of pharmacokinetics and biopharmaceutics. He is Professor Emeritus and former Dean, School of Pharmacy and Pharmaceutical Sciences, University of Manchester and Adjunct Professor, School of Pharmacy, University of California San Francisco. Prof Rowland was formerly Founder and Director of Medeval Ltd (a CRO), Vice-President of the International Pharmaceutical Federation, President of the European Federation of Pharmaceutical Sciences, and is the recipient of the 2007 ACCP Distinguished Investigator Award and the 2012 ASCPT Sheiner-Beal Award in Pharmacometrics.